Startups

Life Sciences Research Partners

Life Sciences Research Partners (LSRP) is an active Belgian nonprofit scientific institution, enterprise BE0435.768.243, supporting biomedical and biotechnology research, training and research commercialization. The legal entity was incorporated June2,1988 as the D. Collen Research Foundation and adopted its current name August28,2007; its published bylaws explicitly preserve the same rights and obligations. Its funding derives mainly from direct and indirect proceeds of KU Leuven tissue-type plasminogen activator intellectual property, rather than external limited-partner fund subscriptions. Research grants, scholarships, academic infrastructure and charitable projects are distinguished from equity investments. Bioxodes identifies LSRP as an institutional investor, with its particular investment round and ticket undisclosed. The association also helped establish Fund+ in2015, a separate Belgian investment company; Fund+ commitments and portfolio are not automatically LSRP cash or direct investments. Its public directory and signed May26,2026 minutes identify four board members, while Fund+ independently confirms Diane De Wyngaert currently provides administrative/bookkeeping support to LSRP. Peter Verhamme and Chris Buyse act as permanent representatives of KU Leuven and SOFIA BV in the2026 minutes. Corporate balance-sheet assets and cash positions are not recorded as LP fund closes. Company classification denotes this nonprofit institutional legal investor and does not imply a for-profit business or venture partnership.

Founded 1988

Team

Chris BuyseBoard Member — SOFIA BV permanent representative

Diane De WyngaertAdministrative and Bookkeeping Support

Désiré CollenFounder and Board Chairman

Peter VerhammeBoard Member — KU Leuven permanent representative

Roger LijnenBoard Member

Investments

$—Unknown date

Bioxodes

Sambrinvest, Life Sciences Research Partners